Seasonal Influenza Vaccine Market to Reach $4 Billion - High Investment & Strict Regulations Act as Barriers - Research and Markets

News provided by

Dec 06, 2016, 07:10 ET

DUBLIN, Dec 6, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Seasonal Influenza Vaccine Market Forecast, 2016 to 2022" drug pipelines to their offering.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against seasonal influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries. The barriers limiting the growth of the influenza market include limited patient awareness regarding the threat of influenza and the importance of influenza vaccinations, high investment and strict regulations act as barriers for new entrants.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projection using a suitable set of assumptions and methodologies. It provides essential insights into seasonal influenza vaccine sales forecasts for the top seven countries, comprising the US, the UK, France, Italy, Spain, Germany and Japan until 2022. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, pipeline and promising vaccines in seasonal influenza vaccine market.

Seven Major Markets(7MM) covered in the report are as follows:

1. United States
2. United Kingdom
3. France
4. Italy
5. Spain
6. Germany
7. Japan

Companies Mentioned:

AstraZeneca
BiondVax Pharmaceuticals Ltd
Daiichi-Sankyo
GlaxoSmithKline (GSK)
Mitsubishi Tanabe Pharma
Novavax
Protein Sciences Corporation
Sanofi Pasteur
Seqirus
VaxInnate

Key Topics Covered:

1. Executive Summary

2. Seasonal Influenza Vaccine Market in Top Seven Countries - Market Overview

3. Seasonal Influenza Vaccine Market Drivers and Barriers

4. Seasonal Influenza Vaccine Market in Top Seven Countries - Geographical Landscape

5. Seasonal Influenza Vaccine Production & Distribution in United States

6. Seasonal Influenza Vaccine Market - Regulatory Landscape

7. Market Dynamics - Mergers, Acquisitions, Key Agreements & Collaborations

8. Seasonal Influenza Vaccine - Pipeline Assessment

9. Seasonal Influenza Vaccine - Clinical Trials Assessment by Phase and Trial Status

10. Key Companies Analysis

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/3slddp/seasonal

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets